To our knowledge, melanoma ICAM-1 upregulation positively correlating with an immunogenic melanoma phenotype has not been previously shown; however, this should be further addressed in the future by additional experimental validations (eg, by performing patient-matched melanoma T-cell killing assays). Here, ICAM1 is linked to melanoma.